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In Italy a national Plan for the surveillance of imported 
and autochthonous human vector-borne diseases (chi-
kungunya, dengue, Zika virus disease and West Nile 
virus (WNV) disease) that integrates human and veter-
inary (animals and vectors) surveillance, is issued and 
revised annually according with the observed epidemi-
ological changes. Here we describe results of the WNV 
integrated veterinary and human surveillance systems 
in Italy from 2008 to 2015. A real time data exchange 
protocol is in place between the surveillance systems 
to rapidly identify occurrence of human and animal 
cases and to define and update the map of affected 
areas i.e. provinces during the vector activity period 
from June to October. WNV continues to cause severe 
illnesses in Italy during every transmission season, 
albeit cases are sporadic and the epidemiology var-
ies by virus lineage and geographic area. The integra-
tion of surveillance activities and a multidisciplinary 
approach made it possible and have been fundamental 
in supporting implementation of and/or strengthen-
ing preventive measures aimed at reducing the risk of 
transmission of WNV trough blood, tissues and organ 
donation and to implementing further measures for 
vector control.
Introduction
West Nile virus (WNV), a single stranded RNA virus of 
the genus Flavivirus, is mostly transmitted by mos-
quito bites, but also through organ transplantation, 
blood transfusion, in the laboratory setting and from 
mother to child during pregnancy, delivery, or breast-
feeding [1]. The virus is maintained in a continuous 
vertebrate-mosquito cycle. Mosquitoes are the vectors 
and birds are the reservoir for West Nile virus. Humans, 
horses and other mammals are considered dead-end 
hosts and do not contribute to further spread of the 
disease.
In humans, ca 80% of infections are asymptomatic, 
20% of those infected may present with fever and or 
influenza-like symptoms, whereas less than 1% i.e. 
mostly the elderly and immunocompromised people, 
develop West Nile neuroinvasive diseases (WNND) 
such as encephalitis, meningo-encephalitis or menin-
gitis that may lead to death [1,2].
In 1996, the first large human outbreak of WND in 
Europe was reported in Romania with 393 confirmed 
cases [3] and since then, the number of WNND cases 
reported in humans increased significantly. From 2002 
to 2009, several WNV outbreaks were reported in a 
few European and neighbouring countries (Albania, 
Bosnia, Bulgaria, Croatia, FYROM, Greece, Hungary, 
Italy, Kosovo, Montenegro, Portugal, Romania, Russia, 
Serbia, Spain, Turkey, Ukraine) [4]. After 2005, an 
endemic transmission cycle started in some south-
eastern and eastern European countries with annual 
outbreaks [5-8], mostly sustained by the rapid spread 
of WNV lineage 2 strains belonging to the Hungarian 
and Volgograd clade [9].
In Italy, the first outbreak of WNV infection was 
reported in 1998 in the region of Tuscany [10] and since 
2001, a national veterinary surveillance plan for WNV 
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based on wild bird mortality and on entomological and 
sentinel animal surveillance has been in place. The 
plan aims at monitoring areas at risk for WNV circula-
tion, and detecting WNV seroconversion in horses in 
these areas [10,11]. In parallel, in 2002, human surveil-
lance recommendations were issued by the Ministry 
of Health requesting all 21 Italian regions and autono-
mous provinces and autonomous provinces to report 
to the national mandatory surveillance system all hos-
pitalised cases of aseptic meningitis and encephalitis 
with unknown aetiology, and cases of fever with rash 
in the areas where veterinary cases where identified. 
Moreover, health authorities were requested to actively 
identify cases and possible WNV seroconversion in 
close contacts of infected animals such as employees 
of stables and veterinarians or people living in the area 
[12].
The veterinary and human surveillance systems did not 
detect any relevant circulation of WNV until 2008, when 
the virus was identified in mosquitoes, birds, horses 
and humans in the area surrounding the Po river delta, 
involving three north Italian regions [2].
Since the re-introduction of the virus in 2008, a con-
stant and intensified WNV circulation across the whole 
of Italy was observed with a geographical spread of 
WNV to the west and south [2,13]. Moreover, from 2008 
to 2011, WNV lineage 1 was responsible for reported 
human WNDD cases, but, since 2011, evidence of exten-
sive circulation of lineage 2 closely related to both the 
Hungarian and Volgograd clades, was demonstrated 
[13-15]. This suggests a possible introduction of line-
age 2 from central and/or eastern European countries, 
probably through migratory birds [16,17].
WNV has caused severe illnesses in humans in Italy 
every season over nearly a decade. However, cases 
occur sporadically and the epidemiology varies accord-
ing to the virus lineage and the affected geographic 
area. Integrated surveillance is essential to identify 
outbreaks in a timely fashion and to guide prevention 
efforts aimed at reducing the incidence of severe cases 
and at reducing the probability of virus transmission 
via blood, tissue and organ donations.
A. Veterinary cases B. Human cases
No reported cases
Earliest seasons (2008-2013)
2014 season
2014 and 2015 seasons
2015 season
Figure 1
Geographical distribution of West Nile neuroinvasive disease in horses (panel A) and humans (panel B), Italy 2008–2015 
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Here we present the evolution of the national surveil-
lance plan in the five years following its first imple-
mentation, and briefly describe results of the WNV 
integrated surveillance system in Italy.
Methods
The integrated veterinary and human 
surveillance systems in Italy
In 2008 and 2011, the national WNV veterinary sur-
veillance plan [18] and the WNND human surveillance 
recommendations [19] were revised, respectively. New 
activities were added including the potential integra-
tion between veterinary (animals and vectors) and 
human surveillance. Provinces with evidence of animal 
and vector or human infections in the previous season 
have to implement active surveillance and manda-
tory screening of blood donations. The veterinary and 
human plans have been published separately and they 
were revised annually according to the epidemiological 
situation in the country. Since 2009, some north Italian 
regions have implemented an integrated surveillance, 
targeting mosquitoes, birds, and humans [15].
Pillars of the national integrated surveillance system 
are (i) the entomological monitoring based on mosquito 
collections in selected sites; (ii) the animal surveil-
lance targeting migratory and resident birds as well as 
horses and poultry; (iii) the human surveillance system 
requesting clinicians to report all possible, probable 
and confirmed WNV cases, irrespective of age, using a 
modified European case definition which includes neu-
rological symptoms in the clinical criteria [2].
For veterinary surveillance purposes, the Italian ter-
ritory was subdivided in two distinct epidemiologi-
cal territories: endemic and non-endemic. The former 
includes the territories where WNV was detected in 
the previous two years. At present these are the plain 
of the Po river valley, including Friuli Venezia Giulia, 
Emilia Romagna, Lombardy, Piedmont, Veneto regions, 
and the two main Italian islands: Sardinia and Sicily. 
The remainder of Italy is considered non-endemic. In 
the endemic territories, an early warning system is in 
place, which enables the reinforcement of the activi-
ties aiming at detecting WNV in vectors and birds [20]. 
In particular, the regions of the plain of the Po river 
i.e. Friuli Venezia Giulia, Emilia Romagna, Lombardy, 
Piedmont, Veneto, operate an enhanced surveillance 
system based on a network of fixed mosquito traps 
(in grids from 10 to 20 km) and on the collection of 
residential wild birds, mainly Corvidae. Timely data on 
viral circulation triggers preventive measures to avoid 
the virus transmission via blood, tissue and organ 
donations [15,21,22].
Figure 2
West Nile virus detections in the veterinary and human surveillance by month, Italy, 2008–2015`
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Data collected through the Veterinary Plan are reg-
istered using an information system (SISMAN) that 
records and manages laboratory results and publishes 
weekly and daily reports describing the outcomes of 
the surveillance activities. A web-based geographic 
information system (WebGIS) was developed for dis-
playing thematic maps and to help the veterinary ser-
vices to explore the area surrounding the outbreak, 
and to create buffers around the reported cases.
Human cases are notified by regional and local 
authorities to the Ministry of Health and to the Istituto 
Superiore di Sanità (ISS, national public health insti-
tute) using a specific password-protected web-based 
system, which permits to report probable and con-
firmed cases, adding available epidemiological (includ-
ing the province of exposure), clinical and laboratory 
information. The web-based system is accessible also 
to the National Blood Center (NBC) and to the National 
Transplant Center (NTC), which implement precaution-
ary measures on blood donation and transplant activi-
ties also on the basis of data on WNV human cases.
In order to rapidly identify, define and update the map 
of the affected areas i.e. provinces during the vector 
activity period, a real-time data exchange protocol is in 
place between the two systems.
Definitions and identification of at risk areas 
in Italy
The national plan for human surveillance defines as 
‘affected areas’ all the provinces (Nomenclature of 
Units for Territorial Statistics (NUTS)-3) [23] where lab-
oratory-confirmed WNV infections in animals, vectors 
or humans, irrespective of age, were notified in the 
previous years or during the surveillance period. The 
‘surveillance period’ covers the months between the 
1 June and 30 October, which is considered the period 
with the highest vector activity. Identification of an 
affected area immediately triggers the definition of the 
‘surveillance area’ for the whole region (NUTS-2 level) 
where the affected area is located. In the surveillance 
area, passive human surveillance has to be set up, and 
physicians are requested to report all possible, prob-
able and confirmed WNND cases. In the affected areas, 
the NBC and the NTC immediately activate the WNV 
screening, by Nucleic Acid Amplification Test (NAT), of 
all blood, blood component, and organ donations until 
the end of the vector season in order to avoid WNV 
transmission [24].
Data analysis
In our analysis we included autochthonous confirmed 
cases of WNND, West Nile fever and infections detected 
in blood and in organ donors; we also analysed data 
on vectors and birds. Annual incidence rates in human 
in the period from 2008 to 2015 were calculated using 
annual resident province population. All population 
data were obtained from the Italian National Institute 
of Statistics (ISTAT) [8]. The statistical analysis was 
carried out using STATA software version 11.2 (Stata 
Corporation, College Station, TX, US). Maps were pro-
duced using Epi Info version 7 (CDC, Atlanta, GA, US).
Figure 3
Human West Nile neuroinvasive disease cases by month of symptom onset and year, Italy 2008–2015 (n=173)
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Results
In Italy from 2008 to 2015, the circulation of WNV was 
reported in mosquitoes, birds and horses in the terri-
tory of 14 regions, with 173 indigenous cases of human 
WNND notified in eight regions (Apulia, Basilicata, 
Emilia-Romagna, Friuli Venezia Giulia, Lombardy, 
Piedmont, Sardinia, Veneto). Figure 1 shows the geo-
graphical distribution of human and equine neuroinva-
sive cases detected in Italy from 2008 to 2015.
Results of the veterinary surveillance from 2008 to 2015 
are reported in Table 1. Since 2008, more than 16,000 
mosquito pools have been tested, with 435 positive 
results, in eight regions and 30 provinces where sub-
sequently human WNND cases were reported. Positive 
mosquito pools without consecutive or previous detec-
tion of WNND in humans were detected in 2008 in the 
province of Brescia, Lombardy region (n=1); in 2011 in 
the province of Messina, Sicily region (n=1) and in 2014 
in the province of Genoa province, Liguria region and in 
the province of Alessandria province, Piedmont region 
(n=2, respectively). 
In the provinces where there were also human cases, 
viral circulation in mosquitoes preceded human WNV 
(WNND and West Nile fever) cases with a mean of 22 
days (range 0–58), except for few provinces (2011: n=1, 
2012: n=2, 2013 and 2015: n=3, respectively) where 
the identification of human cases anticipated the evi-
dence of viral circulation in vectors (Figure 2).
Also from 2008 to 2015, more than 24,000 residential 
birds were examined, with 296 positive results. WNV 
was found in birds in six regions. In the 15 provinces 
where there were human cases, positive birds were 
identified with a mean of 35 days (range 1–315 days) 
before the appearance of human cases.
During 2008 to 2010, all isolated viruses belonged to 
WNV-lineage 1, from 2011 to 2012 lineage 1 and 2 co-
circulated with a higher proportion of lineage 1 and 
from 2013 to 2015 lineage 2 prevailed over lineage 1 
with evidence of lineage 1 circulation only in one prov-
ince each season.
Human cases
The national incidence of WNND peaked in 
2013 (1.66/1,000,0000 inhabitants) and 2015 
(1.34/1,000,0000). From 2008 to 2011, the annual inci-
dence was relatively low (median: 0.41/1,000,000; 
range: 0.11–0.64). From 2012 to 2015, the national 
incidence of WNND increased by threefold (median: 
1.20/1,000,0000; range: 0.78–1.66). The increase in 
disease incidence was initially concentrated in north-
ern Italy moving over time towards the south, mainly 
to areas in central and to some areas in southern Italy. 
However, 91% (157/173) of the WNND cases detected 
during the entire study period were reported from three 
regions (Emilia-Romagna, Lombardy and Veneto) in the 
Po river plain area (Table 2) with the Emilia-Romagna 
and Veneto regions reporting the highest incidence 
(1.60 and 1.46/1,000,000 respectively).
The distribution of human WNND cases by month and 
year of symptom onset is reported in Figure 3.
The median age of cases was 73 years (range: 10–90 
years) during the entire surveillance period, varying 
from a minimum of 67 years (range: 41–68 years) in 
2010 to 77 years (range: 42–89 years) in 2013. Most of 
the reported cases (69%, 120/173) were male. All WNND 
cases were hospitalised: 82 presented as encephalitis, 
44 as meningo-encephalitis, 31 as meningitis, seven as 
polyradiculoneuritis, one as facial paralysis and eight 
as other neurological symptoms: meningeal symptoms 
(n=2), extrapyramidal syndrome (n=1), confusion (n=1), 
headache (n=1), ataxic paraparesis (n=1), neuropathy 
of lower limbs (n=1), symptoms were not specified for 
one case. Eighteen of the 173 WNND cases died (2009: 
n=3; 2011: n=5; 2012: n=1; 2013: n=7; 2014 and 2015: 
n=1 each), corresponding to an overall case fatality rate 
of 10%. The median age of WNND fatal cases was 82 
years (range: 34–89 years), 14 of 18 were male. All fatal 
cases were reported to have chronic conditions before 
symptom onset and 10 presented with encephalitis, six 
with meningo-encephalitis and two with meningitis.
In the entire period, 69 confirmed cases of WNV fever 
were reported to the national surveillance system from 
Table 1
Veterinary surveillance for West Nile virus in birds, mosquitoes, horses and chickens, Italy by year, 2008–2015
Years
Mosquitoes pool Birds Horses Chickens
Tested Positive Tested Positive Tested Positive Tested Positive
2008 152 8 490 45 1,532 563 76 1
2009 217 20 3,753 22 4,430 223 2,517 0
2010 1,068 13 4,182 3 2,728 128 1,213 5
2011 2,113 8 3,026 11 3,424 197 2,505 34
2012 2,366 14 2,260 21 2,081 63 2,461 6
2013 2,324 146 3,761 79 2,735 50 2,363 0
2014 5,834 125 5,368 48 5,882 27 1,974 7
2015 2,300 101 2,147 67 1,313 30 24 1
Total 16,374 435 24,987 296 24,125 1,281 13,133 54
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four Italian regions (Emilia-Romagna n=31, Lombardy 
n=3, Marche n=1, and Veneto n=34).
Situation in 2015
In Italy in 2015, since the beginning of the surveillance 
period, for the first time since 2008, four cases, two 
from Emilia-Romagna and Lombardy region, respec-
tively, all had symptom onset in the last week of July 
(calendar week 31). The last human cases reported had 
onset of symptoms or were detected in mid-September 
and the integrated surveillance detected signals of 
WNV circulation (veterinary cases), for the first time 
ever, in a northern-western region (Piedmont), where 
also one WNND case was reported. Moreover, virus cir-
culation was detected in animals for the first time in 
the southern Italian regions Apulia (1 horse) and Sicily 
(1 chicken), where no human cases were reported. 
In 2015, a total of 316,614 WNV NAT screening tests 
were conducted in blood donors in the affected prov-
inces and 13 asymptomatic donors, six in Emilia 
Romagna and seven in Lombardy were identified. No 
donor or organ transplant recipients were positive for 
WNV among the 168 tested.
Discussion and conclusions
In Italy from 2008 to 2015, the circulation of WNV 
was reported in mosquitoes, birds and horses in the 
territory of 14 regions [10], with 173 auchtotonous 
cases of human WNND notified. [11]. A peak of cases 
was reported in 2013, a second peak was observed in 
2015. From 2008 to 2015, the Italian contribution to the 
European case load increased substantially i.e. from 
a minimum of 11% (14/128) in 2011 to a maximum of 
56% (60/108) in 2015 [3,9]. Moreover, in this period, an 
expansion of the Italian affected areas from the north-
east to the north-west and south was observed.
From 2008 to 2010, only circulation of lineage 1 was 
reported. The complexity of the epidemiological sce-
nario increased in 2011 with the detection of the novel 
lineage 2 which overcame lineage 1 from 2013 to 2015 
and was responsible for both human and animal cases 
[12]. It is not clear why there was more WNV activity 
Table 2
Incidence of human West Nile neuroinvasive disease cases per 1,000,000 inhabitants by province and year, Italy 2008–2015 
(n=173)
Region Province
2008 2009 2010 2011 2012 2013 2014 2015
N. Incidence N. Incidence N. Incidence N. Incidence N. Incidence N. Incidence N. Incidence N. Incidence 
Piedmont Torino 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 1 0.44
Lombardy
Brescia 0 NA 0 NA 0 NA 0 NA 0 NA 2 1.60 1 0.79 0 NA
Cremona 0 NA 0 NA 0 NA 0 NA 0 NA 1 2.76 3 8.28 4 11.06
Lodi 0 NA 0 NA 0 NA 0 NA 0 NA 1 4.43 2 8.73 3 13.07
Mantova 0 NA 2 4.88 0 NA 0 NA 0 NA 6 14.59 2 4.82 3 7.23
Milano 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 4 1.25
Pavia 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 5 9.12 5 9.11
Veneto
Belluno 0 NA 0 NA 0 NA 1 4.68 0 NA 0 NA 0 NA 0 NA
Padova 0 NA 0 NA 0 NA 0 NA 0 NA 1 1.08 0 NA 0 NA
Rovigo 3 12.18 5 20.23 0 NA 0 NA 0 NA 5 20.61 0 NA 1 4.12
Treviso 0 NA 0 NA 0 NA 6 6.75 6 6.85 4 4.54 0 NA 0 NA
Venezia 1 1.18 1 1.17 2 2.33 1 1.16 15 17.72 2 2.36 0 NA 0 NA
Verona 0 NA 0 NA 0 NA 0 NA 0 NA 1 1.10 1 1.08 0 NA
Vicenza 1 1.17 0 NA 1 1.15 0 NA 0 NA 0 NA 0 NA 0 NA
Friuli 
Venezia 
Giulia
Gorizia 0 NA 0 NA 0 NA 0 NA 1 7.15 0 NA 0 NA 0 NA
Pordenone 0 NA 0 NA 0 NA 0 NA 2 6.44 0 NA 0 NA 0 NA
Udine 0 NA 0 NA 0 NA 2 3.69 1 1.87 0 NA 0 NA 0 NA
Emilia-
Romagna
Bologna 1 1.04 2 2.05 0 NA 0 NA 0 NA 1 1.01 1 1.00 2 1.99
Ferrara 2 5.62 5 13.97 0 NA 0 NA 0 NA 5 14.18 0 NA 1 2.82
Modena 0 NA 2 2.91 0 NA 0 NA 0 NA 7 10.17 2 2.85 8 11.39
Parma 0 NA 0 NA 0 NA 0 NA 0 NA 1 2.32 1 2.26 3 6.74
Piacenza 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 2 6.93 1 3.47
Reggio 
nell‘Emilia 0 NA 0 NA 0 NA 0 NA 0 NA 6 11.48 1 1.87 1 1.88
Rimini 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 0 NA 1 2.98
Apulia Foggia 0 NA 0 NA 0 NA 0 NA 0 NA 1 1.59 0 NA 0 NA
Basilicata Matera 0 NA 0 NA 0 NA 0 NA 1 5.00 0 NA 0 NA 0 NA
Sardinia
Oristano 0 NA 0 NA 0 NA 3 18.05 2 12.22 0 NA 0 NA 0 NA
Sassari 0 NA 0 NA 0 NA 1 2.97 0 NA 0 NA 0 NA 0 NA
NA: not applicable.
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in the past 4 years of surveillance (2012–2015) com-
pared to the earlier surveillance period (2008–2011). 
However, virus lineage and virulence, weather condi-
tions, bird population size and immunity, vector den-
sity, and human behaviour, are all factors that play 
a role in determining if, when and where human out-
breaks may occur.
In Europe, since 2008, WNV has spread into areas not 
previously affected, including Greece [25], Portugal 
[26], Turkey [27], and many eastern European coun-
tries (Albania, Bosnia and Herzegovina, Bulgaria, 
Croatia, the former Yugoslav Republic of Macedonia, 
Kosovo under UN Security Council Resolution 1244, 
Montenegro, Serbia) [28-30]. In the same period the 
disease has been reported in Hungary, Israel, Italy, 
Romania, Russia, Spain and Ukraine [2,29]. 
The fact that the WNV has become endemic in Italy 
has brought the local and national Italian authorities 
to strengthen the WNV surveillance system and for this 
reason, probably, Italy is the country with the highest 
number of reported cases in EU, while other EU coun-
tries have different epidemiological situations, with 
different surveillance systems and objectives [31].
Surveillance of WNV circulation requires an interdis-
ciplinary approach given the complexity of the viral 
biological cycle. For this reason, the integration of 
entomological, veterinary and human surveillance 
systems is an essential tool for public health. In fact, 
the veterinary and entomological surveillance activi-
ties are crucial for estimating the public health risk 
associated with WNV, and for the effective and timely 
control of the disease in humans. In Italy, a serious 
effort has been made to strengthen the integration of 
human with veterinary and entomological surveillance, 
reaching tangible results in the prevention of the dis-
ease [3,7]. In addition, since 2014, some Italian regions 
have explored the feasibility of using vector and ani-
mal surveillance data to trigger blood and organ donor 
safety measures. Encouraging results were obtained in 
2014, during a season with high level of transmission. 
In 2015 however, veterinary surveillance did not signal 
WNV circulation before the occurrence of human cases 
in all affected provinces. Still, when province borders 
are not taken strictly into account and the surround-
ing territories are considered, the entomological and 
veterinary surveillance was able to detect the virus 
circulation also in 2015. Veterinary surveillance identi-
fied WNV circulation in some regions (Apulia, Sardinia, 
Sicily) without any human cases. This could be related 
both to the under ascertainment or under notification 
of human cases to the surveillance system or to lim-
ited circulation of the virus between bird and mosquito 
populations in rural areas.
In conclusion, an integrated human, animal and vector 
surveillance is crucial to timely set up preventive meas-
ures, such as the early detection of infected blood 
donors.
The integration of surveillance activities and the multi-
disciplinary approach in Italy might be a good practice 
to be implemented also in other affected countries for 
the identification of viral circulation. They have been 
fundamental to implement and/or strengthen preven-
tive measures aimed at reducing the risk of transmis-
sion of the WNV to humans.
The work that Italy has being doing in the past 8 years 
of surveillance is constantly enriched by an intense 
research activity and also by the development of inno-
vative tools for the quantification of health risk in 
order to implement prevention measures and effective 
control.
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